<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The risk of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> increases in patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) and a growing body of evidence shows the critical role of interleukin (IL-6) in this process </plain></SENT>
<SENT sid="1" pm="."><plain>IL-6 is both a pro- and anti-inflammatory cytokine whose effects are mediated through activation of STAT3 </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies have also demonstrated that IL-6 trans-signaling through its soluble receptor occurs in IBD and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>IL-6 trans-signaling therefore is emerging as an attractive approach to diminish the inflammatory signals in conditions of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The purpose of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemoprevention is to either delay the <z:hpo ids='HP_0003674'>onset</z:hpo> or progression from <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Natural compounds because of their low toxicity render themselves excellent candidates that can be administered over the lifetime of an individual </plain></SENT>
<SENT sid="6" pm="."><plain>With the focus of managing IBD over a long time and preventing <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, we believe that there should be increased research focus on identifying chemopreventive compounds that can render themselves to long term use possibly for the lifetime of predisposed individuals </plain></SENT>
<SENT sid="7" pm="."><plain>Here, we review the role of IL-6 signaling in IBD and <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and underscore the importance of searching for natural compounds that would target the IL-6 trans-signaling pathway as a way to diminish <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory conditions in the gastrointestinal tract and possibly hamper the progression to <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>We propose that effective screening and identification of natural chemopreventive compounds that target IL-6 trans-signaling has important implications for the development of optimal strategies against <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development triggered by <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>